Exagen (XGN) Return on Equity (2019 - 2025)
Exagen's Return on Equity history spans 7 years, with the latest figure at 1.12% for Q4 2025.
- For Q4 2025, Return on Equity rose 23.0% year-over-year to 1.12%; the TTM value through Dec 2025 reached 1.12%, up 23.0%, while the annual FY2025 figure was 1.48%, 54.0% down from the prior year.
- Return on Equity reached 1.12% in Q4 2025 per XGN's latest filing, down from 0.97% in the prior quarter.
- In the past five years, Return on Equity ranged from a high of 0.21% in Q2 2021 to a low of 1.95% in Q1 2025.
- Average Return on Equity over 5 years is 0.87%, with a median of 0.96% recorded in 2023.
- Peak YoY movement for Return on Equity: rose 27bps in 2024, then crashed -104bps in 2025.
- A 5-year view of Return on Equity shows it stood at 0.31% in 2021, then tumbled by -222bps to 0.98% in 2022, then increased by 4bps to 0.94% in 2023, then tumbled by -43bps to 1.35% in 2024, then rose by 17bps to 1.12% in 2025.
- Per Business Quant, the three most recent readings for XGN's Return on Equity are 1.12% (Q4 2025), 0.97% (Q3 2025), and 1.24% (Q2 2025).